The magnitude of weight loss observed suggests retatrutide may represent a new benchmark in anti-obesity therapy pending FDA approval
Direct-to-Consumer Pricing Was Already Cheaper Before the government deal, both companies launched direct-pay programs: LillyDirect (Zepbound) ~$500$600/month NovoCare (Wegovy/Ozempic) ~$499$650/month Costco ~ $499/month for a 4-week supply Expected to drop toward $350 $245 as the new deal phases in These prices became possible for one reason: They cut out the middlemen
MOTS-c, as a mitochondrial-derived peptide, offers a unique approach to enhancing cellular energy, improving insulin sensitivity, and counteracting age-related metabolic decline by optimizing foundational cellular processes, particularly through AMPK activation and mitochondrial function
That policy was cemented in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
However, it is equally common to feel no significant difference initially, which does not indicate the medication is ineffective
This type of medication works in the same way as a group of hormones called incretins